Itay & Beyond
Patient-derived lab grown brain tissue on a chip, to develop novel treatments for neurology and psyc
Startup Pre-Funding Health Tech & Life Sciences Est. 2021
🌐 WebsiteLinkedInTwitter
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
2
11-50 employees
Confidence
60/100
News
2
articles
About
Itay & Beyond is a pioneering biotech startup revolutionizing neuropsychiatric drug discovery through its platform. The company is driven by the urgent need for more effective treatments in neuropsychiatry.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDigital Healthcare
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnologyHealthcarePatients
Tags
drug-discoveryneuroscience
News (2)
Feb 23, 2025 · www.timesofisrael.com
Biotech startup Itay & Beyond uses AI analysis of a ‘brain-on-a-chip’ made from stem cells to predict drug efficacy for neuropsychiatric disorders, expedite testing and development
Jan 26, 2025 · www.jpost.com
growth-positive
Autism, epilepsy meet next-gen medicine with Israel’s brain chip innovation
Product StagePartners
Details
Product Stage
R&D
Employees
11-50
Exact Count
15
District
Jerusalem District
Founded
2021
Locations
Jerusalem, Israel
Links
Website
itayandbeyond.com/
LinkedIn
Profile
Twitter
Profile
Admin
Last Update
Mar 6, 2025
Verified by
Matan Eblagon
Missing
sector, tags, business model, description, video or image, funding rounds, markets, not claimed
Team (2)
Nissim Perets
Co-founder and CEO
Founder
Nir Waiskopf
VP R&D
Internal
Created by
Matan Eblagon (matane@sncentral.org)
Created
2025-03-05T00:00:00.000Z
Finder · Itay & Beyond · 2026